• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型野生型异柠檬酸脱氢酶 1(IDH1)抑制模式:His315 的直接共价修饰。

Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.

出版信息

J Med Chem. 2018 Aug 9;61(15):6647-6657. doi: 10.1021/acs.jmedchem.8b00305. Epub 2018 Jul 30.

DOI:10.1021/acs.jmedchem.8b00305
PMID:30004704
Abstract

IDH1 plays a critical role in a number of metabolic processes and serves as a key source of cytosolic NADPH under conditions of cellular stress. However, few inhibitors of wild-type IDH1 have been reported. Here we present the discovery and biochemical characterization of two novel inhibitors of wild-type IDH1. In addition, we present the first ligand-bound crystallographic characterization of these novel small molecule IDH1 binding pockets. Importantly, the NADPH competitive α,β-unsaturated enone 1 makes a unique covalent linkage through active site H315. As few small molecules have been shown to covalently react with histidine residues, these data support the potential utility of an underutilized strategy for reversible covalent small molecule design.

摘要

IDH1 在许多代谢过程中起着关键作用,并且在细胞应激条件下充当细胞溶质 NADPH 的主要来源。然而,报道的野生型 IDH1 的抑制剂很少。在这里,我们介绍了两种新型野生型 IDH1 抑制剂的发现和生化特性。此外,我们还介绍了这些新型小分子 IDH1 结合口袋的首次配体结合晶体学特征。重要的是,NADPH 竞争性的α,β-不饱和烯酮 1 通过活性位点 H315 形成独特的共价键。由于很少有小分子被证明与组氨酸残基发生共价反应,这些数据支持了一种未充分利用的策略,用于可逆共价小分子设计的潜在效用。

相似文献

1
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.新型野生型异柠檬酸脱氢酶 1(IDH1)抑制模式:His315 的直接共价修饰。
J Med Chem. 2018 Aug 9;61(15):6647-6657. doi: 10.1021/acs.jmedchem.8b00305. Epub 2018 Jul 30.
2
Discovery and structure-activity-relationship study of novel imidazole cyclopropyl amine analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors.新型咪唑环丙胺类似物作为突变异柠檬酸脱氢酶1(IDH1)抑制剂的发现及构效关系研究
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3808-3812. doi: 10.1016/j.bmcl.2018.07.002. Epub 2018 Jul 4.
3
Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors.新型构象受限茚满类似物作为突变型异柠檬酸脱氢酶1(IDH1)抑制剂的发现及构效关系研究
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5262-5266. doi: 10.1016/j.bmcl.2017.10.029. Epub 2017 Oct 16.
4
Novel Insights for Inhibiting Mutant Heterodimer IDH1 in Cancer: An In-Silico Approach.新型抑制癌症中突变异二聚体 IDH1 的方法:一种计算机模拟方法。
Mol Diagn Ther. 2018 Jun;22(3):369-380. doi: 10.1007/s40291-018-0331-2.
5
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.突变型异柠檬酸脱氢酶IDH1强效抑制剂的生化、细胞及生物物理特性分析
J Biol Chem. 2014 May 16;289(20):13717-25. doi: 10.1074/jbc.M113.511030. Epub 2014 Mar 25.
6
Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective.突变型异柠檬酸脱氢酶 1 和 2(mIDH1/2)抑制剂:更新与展望。
J Med Chem. 2018 Oct 25;61(20):8981-9003. doi: 10.1021/acs.jmedchem.8b00159. Epub 2018 Jun 18.
7
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule.通过变构小分子破坏金属结合网络对突变型异柠檬酸脱氢酶1(IDH1)进行选择性抑制。
J Biol Chem. 2015 Jan 9;290(2):762-74. doi: 10.1074/jbc.M114.608497. Epub 2014 Nov 12.
8
Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1.异柠檬酸脱氢酶1致癌突变的结构分析
Mol Biosyst. 2016 Jun 21;12(7):2276-87. doi: 10.1039/c6mb00182c.
9
Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1.新型强效选择性突变异柠檬酸脱氢酶1抑制剂3-吡嗪-2-基-恶唑烷-2-酮的设计、合成及生物活性
Bioorg Med Chem. 2017 Dec 15;25(24):6379-6387. doi: 10.1016/j.bmc.2017.10.009. Epub 2017 Oct 13.
10
Discovery of DC_H31 as potential mutant IDH1 inhibitor through NADPH-based high throughput screening.通过基于 NADPH 的高通量筛选发现潜在的突变 IDH1 抑制剂 DC_H31。
Bioorg Med Chem. 2019 Aug 1;27(15):3229-3236. doi: 10.1016/j.bmc.2019.05.040. Epub 2019 May 28.

引用本文的文献

1
Cytoplasmic Isocitrate Dehydrogenase Neomorphic G98N and R133H Mutants Produce the Oncometabolite 2-Hydroxyglutarate.细胞质异柠檬酸脱氢酶的新形态G98N和R133H突变体产生致癌代谢物2-羟基戊二酸。
Int J Mol Sci. 2025 Aug 25;26(17):8238. doi: 10.3390/ijms26178238.
2
Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Oxidoreductase Enzyme DsbA.一种选择性靶向氧化还原酶DsbA中组氨酸残基的丙二烯弹头的鉴定。
ACS Med Chem Lett. 2025 Mar 22;16(4):625-630. doi: 10.1021/acsmedchemlett.5c00016. eCollection 2025 Apr 10.
3
Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.
单细胞多组学分析确定代谢相关的表观遗传重编程是治疗抵抗性髓母细胞瘤的驱动因素。
Res Sq. 2024 Dec 13:rs.3.rs-5522707. doi: 10.21203/rs.3.rs-5522707/v1.
4
Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma.胶质母细胞瘤中分子生物标志物的演变与精准分子治疗策略
Cancers (Basel). 2024 Oct 29;16(21):3635. doi: 10.3390/cancers16213635.
5
Targeting a key protein-protein interaction surface on mitogen-activated protein kinases by a precision-guided warhead scaffold.通过精准制导弹头支架靶向丝裂原活化蛋白激酶的关键蛋白-蛋白相互作用表面。
Nat Commun. 2024 Oct 4;15(1):8607. doi: 10.1038/s41467-024-52574-1.
6
Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp.基于肽的共价抑制剂,带有温和亲电试剂,靶向细菌滑动夹的保守组氨酸残基。
JACS Au. 2024 Jan 25;4(2):432-440. doi: 10.1021/jacsau.3c00572. eCollection 2024 Feb 26.
7
An update on the discovery and development of reversible covalent inhibitors.可逆共价抑制剂的发现与开发进展
Med Chem Res. 2023;32(6):1039-1062. doi: 10.1007/s00044-023-03065-3. Epub 2023 Apr 29.
8
Redox Homeostasis and Beyond: The Role of Wild-Type Isocitrate Dehydrogenases for the Pathogenesis of Glioblastoma.氧化还原平衡及其他:野生型异柠檬酸脱氢酶在胶质母细胞瘤发病机制中的作用。
Antioxid Redox Signal. 2023 Nov;39(13-15):923-941. doi: 10.1089/ars.2023.0262. Epub 2023 Jun 20.
9
Epigenetic Abnormalities in Chondrosarcoma.软骨肉瘤中的表观遗传学异常。
Int J Mol Sci. 2023 Feb 25;24(5):4539. doi: 10.3390/ijms24054539.
10
Covalent drugs targeting histidine - an unexploited opportunity?靶向组氨酸的共价药物——一个未被开发的机会?
RSC Med Chem. 2022 Sep 28;13(10):1121-1126. doi: 10.1039/d2md00258b. eCollection 2022 Oct 19.